JCT Lev Academic Institute

West Jerusalem, Israel

JCT Lev Academic Institute

West Jerusalem, Israel
SEARCH FILTERS
Time filter
Source Type

Trop-Steinberg S.,JCT Lev Academic Institute | Azar Y.,Hebrew University of Jerusalem
The American journal of the medical sciences | Year: 2017

The inflammatory response is known to have a significant role in certain autoimmune diseases and malignancies. We review current knowledge regarding the functions of activator protein 1 (AP-1) as an important modulator in several immune disorders and carcinomas. AP-1 is overexpressed in rheumatoid arthritis and in long-term allogeneic hematopoietic stem cell transplantation survivors; however, decreased expression of AP-1 has been observed in psoriasis, systematic lupus erythematosus and in patients who do not survive after hematopoietic stem cell transplantation. AP-1 also is implicated in the control of various cancer cells. Higher levels of AP-1 components are present in breast and endometrial carcinomas, colorectal cancer and in acute myeloid leukemia, Hodgkin׳s lymphoma and anaplastic large cell lymphoma, with downregulation in ovarian and gastric carcinomas and in patients with chronic myelogenous leukemia. AP-1 may enable the development of helpful markers to identify early-stage disease or to predict severity. Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Loading JCT Lev Academic Institute collaborators
Loading JCT Lev Academic Institute collaborators